Press "Enter" to skip to content

New patent for Bausch drug DUOBRII

0
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for DUOBRII
Annual Drug Patent Expirations for DUOBRII

Duobrii is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.

DUOBRII drug price trends.

Drug patent litigation for DUOBRII.

This drug has forty-five patent family members in twenty-two countries.

The generic ingredient in DUOBRII is halobetasol propionate; tazarotene. One supplier is listed for this compound. Additional details are available on the halobetasol propionate; tazarotene profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

    Leave a Reply

    DrugPatentWatch - Make Better Decisions